Global Direct-To-Consumer Laboratory Testing Market Report and Forecast 2024-2032

Global Direct-To-Consumer Laboratory Testing Market Outlook

The global direct-to-consumer laboratory testing market size was valued at USD 12.4 billion in 2023, driven by the rising prevalence of telemedicine and EHR services across the globe. The market is expected to grow at a CAGR of 26.8% during the forecast period of 2024-2032, with the values likely to rise from USD 15.7 billion in 2024 to USD 105 billion by 2032.

Direct-To-Consumer Laboratory Testing: Introduction

Direct to consumer laboratory testing involves providing the customer with a generated lab test, where they get direct results from the test without engaging with a physician. It has gained high popularity owing to their rapid, accurate and convenient results. DTC testing may not be available for all diseases but they can help in monitoring a prevailing health condition or identify an infectious disease like COVID-19.

Global Direct-To-Consumer Laboratory Testing Market Analysis

Direct to customer lab tests have become highly common after the sudden outbreak of COVID-19. People have become more familiar and comfortable to at home lab tests. Apart from COVID-19, pregnancy test kits also hold a significant share of the market.

The direct-to-consumer laboratory testing market value is driven by the rising digital and artificial intelligence integration and EHR (electronic health record) prevalence. Local testing labs like LigoLab has launched their own consumer portal to facilitate prompt and convenient delivery of results. These platforms are HIPAA compliant and integrate other medical system software as well. With a vision to go beyond at-home testing, companies like Everly Health have been developing virtual care services for effective diagnostic testing, treatment, and ongoing condition management.

In July 2023, Quest Diagnostics launched the first direct to consumer blood test that works by detecting abnormal levels of beta amyloid. The test is aimed at adults aged 18 years or older with Alzheimer running in the family history or with mild dementia. If the results turn out to be positive, then the patient is directly contacted by a doctor. Such services are projected to fuel the direct to customer laboratory testing market growth in the upcoming years.

Global Direct-To-Consumer Laboratory Testing Market Segmentation

Market Breakup by Sample Type

• Blood

• Urine

• Saliva

• Others

Market Breakup by Test Type

• Genetic Testing

• Disease Risk Assessment Testing

• CBC

• Diabetes Testing

• TSH Testing

• Others

Market Breakup by Distribution Channel

• Online Platforms/Websites

• Mobile Applications

• Physical Retail Locations

• Telemedicine Services

• Others

Market Breakup by End User

• Hospitals

• Clinics

• Specialty Labs

• Diagnostic Centres

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Direct-To-Consumer Laboratory Testing Market Overview

North America has held a major portion of the direct-to-consumer laboratory testing market share owing to a well organised medical infrastructure. Healthcare professionals have also worked on educating common people with appropriate utilisation of latest technologies. In addition, the increasing innovation due to presence of impactful healthcare companies is a major factor for driving growth. Europe is a key player holding significant part of the market size.

To meet the rising direct-to-consumer laboratory testing market demand, Asia Pacific region has been observing an increase in the at home test kits manufacturing. Being home to a massive percentage of geriatric population, direct-to-consumer laboratory tests come in handy as the older generation cannot physically move all the time. To ensure easy access to test results, the companies have started providing both soft and hard copy of the test results.

Global Direct-To-Consumer Laboratory Testing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• LabCorp

• Quest Diagnostics

• Everlywell

• LetsGetChecked

• HealthTap

• AncestryDNA

• Veritas Genetics

• MyHeritage

• Color Genomics

• Helix

• Orig3n

• Pathway Genomics

• Thermo Fisher Scientific

• Genome Medical

• HealthCheck

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report